Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of non-MMC trabeculectomy with DexNP vs MMC trabeculectomy with Maxidex
2013-001093-16Phase 2Completed
- Sponsor
- Oculis
- Start
- Jun 2013
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of OCS-01 in Glaucoma (2 arms), sponsored by Oculis. Primary endpoint: Complete surgical success rate. Started Jun 2013; status: completed.
02
Drugs
OCS-01
03
Conditions
Glaucoma
Beyond the preview
Go deeper on 2013-001093-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001093-16.